Kit for radiopharmaceutical preparation of a radiopharmaceutical diagnostic drug. DMSA is radiolabelled with Sodium pertechnetate (99mTc) for injection.
It is used for: static renal scintigraphy, renal scintigraphy, in case that other diagnostic methods (e.g. ultrasonography) are not sufficient enough for a diagnosis; detection of change of focal renal parenchyma (e.g. on renal infarction), detection of normvariation such as atypic double-kidney, small kidney, dysplastic kidney, horseshoe kidney as well as for detection of ectopical kidneys, confi rmation of a missing kidneyfunction on multicystic kidneys;
Please see SPC for full list of indications.
Active pharmaceutical ingredient:
succimer (DMSA) 1.0 mg
stannous chloride dehydrate 0.42 mg, ascorbic acid 0.1 mg, sodium hydroxide 0.2 mg, hydrochloric acid 36 % 0.02 mg, nitrogen
labelling activity: up to 3 GBq
labelling volume: 5 ml
incubation time: 1 0 minutes (at room temperature)
Final dilution: up to 10ml
Shelf life after labelling: 4 hrs.
Storage conditions: 2 – 8 °C
Vials/ kit: 5